Bifidobacterium breve BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway
IntroductionThis study investigates the potential of Bifidobacterium breve BB05 (BB05) in mitigating depressive symptoms in a mouse model of Chronic Unpredictable Mild Stress (CUMS), with fluoxetine as a positive control.Methods and ResultsHigh-dose BB05 (1.0 × 109 CFU/kg, BB05H) significantly reduc...
Saved in:
Main Authors: | Yanni Pan, Qingling Huang, Yuan Liang, Yuwuqi Xie, Fang Tan, Xingyao Long |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1529566/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DRAM1 enhances the proliferation and metastasis of gastric cancer through the PI3K/AKT/mTOR signaling pathway and energy metabolism
by: Xinrong Wu, et al.
Published: (2025-01-01) -
Studying the impact of chitosan salicylaldehyde/schiff base/CuFe2O4 in PC3 cells via theoretical studies and inhibition of PI3K/AKT/mTOR signalling
by: Ghada H. Elsayed, et al.
Published: (2025-02-01) -
Spinal Involvement of TRPV1 and PI3K/AKT/mTOR Pathway During Chronic Postoperative Pain in Mice
by: Gabriela Xavier Santos, et al.
Published: (2025-01-01) -
GNG2 inhibits brain metastases from colorectal cancer via PI3K/AKT/mTOR signaling pathway
by: Chenhua Luo, et al.
Published: (2025-01-01) -
Ginsenoside Rg1 alleviates chronic testicular damage caused by cranial irradiation through the SCF/PI3K/Akt/mTOR pathway in mice
by: Qiuhua Zhou, et al.
Published: (2025-02-01)